1039733-52-2Relevant academic research and scientific papers
2,4-Diamino-quinazolines as inhibitors of β-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer
Chen, Zecheng,Venkatesan, Aranapakam M.,Dehnhardt, Christoph M.,Santos, Osvaldo Dos,Santos, Efren Delos,Ayral-Kaloustian, Semiramis,Chen, Lei,Geng, Yi,Arndt, Kim T.,Lucas, Judy,Chaudhary, Inder,Mansour, Tarek S.
scheme or table, p. 4980 - 4983 (2010/03/24)
The synthesis and SAR of a series of 2,4-diamino-quinazoline derivatives as β-catenin/Tcf-4 inhibitors are described. This series was developed by modifying the initial lead 1, which was identified by screening of our compound library and found to inhibit
AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS
-
Page/Page column 81; 82, (2008/12/07)
The present invention relates to amino-substituted quinazoline derivatives as inhibitors of β-catenin/tcf-4 pathway, which can be useful in the treatment of cancer; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.
